-
2024 South-North Forum | Prof. Junjie Li: What’s Next for Neoadjuvant Therapy in HER2-Positive Breast Cancer?
Targeted therapy has always been a critical component of systemic treatment for HER2-positive breast cancer patients. Currently, small-molecule tyrosine kinase inhibitors (TKIs) are commonly used HER2-targeted therapies. What role do TKIs play in the neoadjuvant treatment of HER2-positive breast cancer, and what drug combinations yield the best treatment outcomes? At the 2024 South-North Forum, Prof.…
-
Professor Wenjun Zhang: Focusing on Clinical Application, Key Updates in the 2024 CSCO CAR-T Cell Therapy Guidelines | 2024 CSCO Guidelines Conference
As scheduled, the 2024 China Society of Clinical Oncology (CSCO) guidelines conference has arrived, with many CSCO oncology treatment guidelines being updated or published for the first time. In the field of hematologic oncology, the much-anticipated CAR-T cell therapy guidelines have been significantly updated. The “CSCO CAR-T Cell Therapy for Malignant Hematological Diseases and Management…
-
A Case of Extensive Portal Venous System Thrombosis and Prehepatic Portal Hypertension Following Transition from Low to High Altitude
To broaden the horizons and enrich the practical knowledge of clinical hepatologists, and to cultivate clinical thinking abilities, International Liver Disease has invited Professor Shanhong Tang’s team from the Department of Gastroenterology at Western Theater Command General Hospital to create the “Liver Difficult Cases” column. This column compiles “classic cases” encountered by Professor Tang’s team…
-
Professor Jianming Guo : Enhancing Perioperative Predictive Performance for Kidney Cancer Patients with AI-Assisted Surgical Scoring Systems
Kidney cancer surgical scoring systems provide critical information for treatment planning, surgical method selection, tumor recurrence risk, and patient prognosis. The 39th Annual Congress of the European Association of Urology (EAU24) was held from April 5 to 8, 2024, in Paris, France, where numerous studies and advancements related to kidney cancer surgery were presented. Oncology…
-
Professor Jing Yao: Advancing Clinical Practice with Personalized Treatment Strategies for Breast Cancer Patients丨Jiangcheng Breast Cancer Academic
In early March, as the spring begins in Jiangcheng, the cherry blossoms bloom following the plum blossoms. The 4th Jiangcheng Breast Cancer Academic Forum was successfully held in Wuhan. Experts in breast cancer surgery, medical oncology, radiotherapy, and basic and translational research gathered to present numerous research advancements and clinical development trends. After the conference,…
-
Bispecific CAR T Cell Therapy Targeting BCMA and CD19 in Relapsed/Refractory Multiple Myeloma: A Phase I/II Clinical Trial
In the evolving landscape of hematology and oncology, innovative treatments for challenging conditions like relapsed or refractory multiple myeloma (R/R MM) are of paramount importance. It is in this context that the recent phase I/II, open-label study investigating the efficacy of bispecific CAR-T cell therapy targeting BCMA and CD19 comes to light, marking a significant…
-
EAU24 Expert Commentary丨Professor Tongyi Men: Bringing More Hope to Kidney Cancer Patients Through the Latest Research Advances
The situation of urological tumors in China is not optimistic, with the incidence of kidney cancer increasing annually by 4% to 7%. There is an urgent need to explore new diagnostic and therapeutic strategies to improve incidence rates and patient prognosis. The 39th Annual Congress of the European Association of Urology (EAU24) was held from…
-
2024 South-North Forum | Prof. Zhiming Shao: Breast Cancer Treatment in the Era of Precision Typing
Breast diseases have the highest incidence among women, with breast cancer being the leading malignant tumor threatening women’s health. From “one-size-fits-all” treatments to “individualized therapy” based on patients, the exploration of breast cancer treatment has been ongoing for centuries. At the 2024 South-North Forum, Prof. Zhiming Shao from Fudan University Cancer Hospital presented a report…
Connecting Medical Expertise through Media